- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- April 2021
- 94 Pages
Global
From €1327EUR$1,375USD£1,138GBP
€2654EUR$2,750USD£2,277GBP
- Book
- October 2019
- 192 Pages
- Book
- November 2018
- 528 Pages
- Book
- December 2020
Global
Malignant Melanoma is a type of skin cancer that is caused by the uncontrolled growth of pigment-producing cells in the skin. It is the most serious form of skin cancer and can spread to other parts of the body if not treated early. Dermatologists are the primary healthcare professionals responsible for diagnosing and treating malignant melanoma. They use a variety of methods to diagnose the disease, including physical examination, biopsy, and imaging tests. Treatment options for malignant melanoma include surgery, radiation therapy, chemotherapy, and immunotherapy.
The malignant melanoma market is a rapidly growing segment of the dermatology market. It is driven by the increasing prevalence of skin cancer, the development of new treatments, and the growing awareness of the importance of early diagnosis and treatment. Companies in the malignant melanoma market include Novartis, Merck, Bristol-Myers Squibb, Roche, and Pfizer. Show Less Read more